EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Cardioprotective and Vasoprotective Effects of Corticotropin-Releasing Hormone and Urocortins: Receptors and Signaling

Sergey V Popov, Ekaterina S Prokudina, Alexander V Mukhomedzyanov, Natalia V Naryzhnaya, Huijie Ma, Jitka M Zurmanova, Peter F M van der Ven, Leonid N Maslov iD

Journal of Cardiovascular Pharmacology and Therapeutics · 2021-11 · 26 (6) · 575-584

DOI: 10.1177/1074248420985301 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Cardiovascular Pharmacology and Therapeutics, online erschienen am 05.08.2021. Verfasst von Sergey V Popov und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Experimental Cardiology, Cardiology Research Institute, 164253Tomsk National Research Medical Center of the RAS, Tomsk, Russia. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 75 Literaturangaben. Gefördert von: Russian Foundation of Basic Research, State assignments, Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the recent progress in research and therapy, cardiovascular diseases are still the most common cause of death worldwide, thus new approaches are still needed. The aim of this review is to highlight the cardioprotective potential of urocortins and corticotropin-releasing hormone (CRH) and their signaling. It has been documented that urocortins and CRH reduce ischemic and reperfusion (I/R) injury, prevent reperfusion ventricular tachycardia and fibrillation, and improve cardiac contractility during reperfusion. Urocortin-induced increase in cardiac tolerance to I/R depends mainly on the activation of corticotropin-releasing hormone receptor-2 (CRHR2) and its downstream pathways including tyrosine kinase Src, protein kinase A and C (PKA, PKCε) and extracellular signal-regulated kinase (ERK1/2). It was discussed the possibility of the involvement of interleukin-6, Janus kinase-2 and signal transducer and activator of transcription 3 (STAT3) and microRNAs in the cardioprotective effect of urocortins. Additionally, phospholipase-A2 inhibition, mitochondrial permeability transition pore (MPT-pore) blockade and suppression of apoptosis are involved in urocortin-elicited cardioprotection. Chronic administration of urocortin-2 prevents the development of postinfarction cardiac remodeling. Urocortin possesses vasoprotective and vasodilator effect; the former is mediated by PKC activation and prevents an impairment of endothelium-dependent coronary vasodilation after I/R in the isolated heart, while the latter includes both cAMP and cGMP signaling and its downstream targets. As CRHR2 is expressed by both cardiomyocytes and vascular endothelial cells. Urocortins mediate both endothelium-dependent and -independent relaxation of coronary arteries.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnimalsCardiovascular DiseasesCardiovascular Physiological PhenomenaCardiovascular SystemCorticotropin-Releasing HormoneHormonesHumansRatsReperfusion InjuryUrocortinsVasodilation

Stichwörter der Autor:innen

corticotropin-releasing hormoneheartischemiareperfusionurocortins

Substanzen

HormonesUrocortinsCorticotropin-Releasing Hormone

Autor:innen und Institutionen

  • Laboratory of Experimental Cardiology, Cardiology Research Institute, 164253Tomsk National Research Medical Center of the RAS, Tomsk, Russia.
  • Department of Physiology, 12553Hebei Medical University, Shijiazhuang, Hebei Province, China.
  • Department of Physiology, Faculty of Science, 37740Charles University, Prague, Czech Republic.
  • Department of Molecular Cell Biology, Institute for Cell Biology, 9374University of Bonn, Bonn, Germany.

ORCID-Profile: Leonid N Maslov

Förderung

  • Russian Foundation of Basic Research
  • State assignments
  • Russian Science Foundation

Zitieren

APA

Popov, S. V., Prokudina, E. S., Mukhomedzyanov, A. V., Naryzhnaya, N. V., Ma, H., Zurmanova, J. M., der Ven, P. F. M. V., & Maslov, L. N. (2021). Cardioprotective and Vasoprotective Effects of Corticotropin-Releasing Hormone and Urocortins: Receptors and Signaling. Journal of Cardiovascular Pharmacology and Therapeutics, 26(6), 575-584. https://doi.org/10.1177/1074248420985301

Vancouver

Popov SV, Prokudina ES, Mukhomedzyanov AV, Naryzhnaya NV, Ma H, Zurmanova JM, et al. Cardioprotective and Vasoprotective Effects of Corticotropin-Releasing Hormone and Urocortins: Receptors and Signaling. Journal of Cardiovascular Pharmacology and Therapeutics. 2021;26(6):575-584. doi:10.1177/1074248420985301

BibTeX
@article{Popov2021,
  author = {Popov, Sergey V and Prokudina, Ekaterina S and Mukhomedzyanov, Alexander V and Naryzhnaya, Natalia V and Ma, Huijie and Zurmanova, Jitka M and der Ven, Peter F M van and Maslov, Leonid N},
  title = {Cardioprotective and Vasoprotective Effects of Corticotropin-Releasing Hormone and Urocortins: Receptors and Signaling},
  journal = {Journal of Cardiovascular Pharmacology and Therapeutics},
  year = {2021},
  volume = {26},
  number = {6},
  pages = {575--584},
  doi = {10.1177/1074248420985301}
}
Kostenlos starten →